OptimizeRx Corp Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
OptimizeRx Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2022.
  • OptimizeRx Corp Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $2.91M, a 28.5% increase year-over-year.
  • OptimizeRx Corp Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $16.4M, a 132% increase year-over-year.
  • OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2022 was $15.7M, a 187% increase from 2021.
  • OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2021 was $5.49M, a 73.1% increase from 2020.
  • OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2020 was $3.17M, a 40.4% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $15.7M +$10.3M +187% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-10
2021 $5.49M +$2.32M +73.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $3.17M +$913K +40.4% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-03-10
2019 $2.26M -$261K -10.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-08
2018 $2.52M +$1.62M +179% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 $902K +$343K +61.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 $559K -$21.8K -3.75% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-08
2015 $581K -$591K -50.4% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-08
2014 $1.17M +$649K +124% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-15
2013 $523K Jan 1, 2013 Dec 31, 2013 10-K/A 2015-09-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.